Cases of human infection with highly pathogenic strains of the avian influenza A virus: risks and vaccination strategies
Authors:
- Elena I. BurtsevaEBElena I. Burtseva
- Anastasia S. KrepkaiaAKAnastasia S. Krepkaia
- Anna V. IgnatievaAIAnna V. Ignatieva
- Крепкая Анастасия СергеевнаКСКрепкая Анастасия Сергеевна
Open Access
- 31 December 2025
- journal article
- Published by ECO-Vector LLC (Publications) in Epidemiology and Infectious Diseases
- Vol. 30 (4) , 235-246
Abstract
For several decades, avian influenza viruses have been considered a source of new variants with pandemic potential based on all known influenza pandemics to date. This review provides examples of human infections with various subtypes of avian influenza A viruses since 1997, when the first cases of human infection with highly pathogenic (H5N1) avian influenza viruses were reported in Hong Kong. In recent years, the World Health Organization has reported the largest number of human avian influenza virus infections in the Pacific region. An unusual outbreak of avian influenza A(H5N1) has been documented among cows and birds in the United States, with some farmers being infected as well. The article presents an analysis of infection risks, the properties and structure of strains, and their susceptibility to direct-acting antivirals. It also discusses vaccine development approaches, the strategy and tactics of vaccination within the WHO Pandemic Influenza Preparedness Framework and the Global Influenza Strategy.Keywords
This publication has 49 references indexed in Scilit:
- The global H5N1 influenza panzootic in mammalsNature, 2024
- The episodic resurgence of highly pathogenic avian influenza H5 virusNature, 2023
- Rapid evolution of A(H5N1) influenza viruses after intercontinental spread to North AmericaNature Communications, 2023
- mRNA vaccines against H10N8 and H7N9 influenza viruses of pandemic potential are immunogenic and well tolerated in healthy adults in phase 1 randomized clinical trialsVaccine, 2019
- Influenza A(H5N8) virus isolation in Russia, 2014Archives of Virology, 2015
- ISCOMATRIX™ adjuvant promotes epitope spreading and antibody affinity maturation of influenza A H7N9 virus like particle vaccine that correlate with virus neutralization in humansVaccine, 2015
- H5N1 influenza virus-like particle vaccine protects mice from heterologous virus challenge better than whole inactivated virusVirus Research, 2015
- Intranasal vaccination with H5, H7 and H9 hemagglutinins co-localized in a virus-like particle protects ferrets from multiple avian influenza virusesVirology, 2013
- Influenza virus-like particles comprised of the HA, NA, and M1 proteins of H9N2 influenza virus induce protective immune responses in BALB/c miceVaccine, 2005
- Characterization of a human H9N2 influenza virus isolated in Hong KongVaccine, 2001